This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Schizophrenia
  • /
  • Cannabidiol (CBD) as an Adjunctive Therapy in Schi...
Journal

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.

Read time: 1 mins
Published:15th Dec 2017
Author: McGuire P, Robson P, Cubala WJ, Vasile D, Morrison PD, Barron R et al.
Availability: Pay for access, or by subscription
Ref.:Am J Psychiatry. 2017:appiajp201717030325.
DOI:10.1176/appi.ajp.2017.17030325
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest